Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
Generium

May 2026

Generium Market Share Analysis for May 2026

ао «генериум» - российский лидер в области биотехнологических разработок и производства. исследования, производственные мощности компании. вакансии.
Year Founded2009
Employees1001 - 5000
Annual Revenue$5M - $10M
generium.ru
Generium
Generium (including company regionals)
  • generium.ru
    generium.ru
See more website traffic and engagement information

Generium Revenue up to May 2026 is 5M - 10M

revenue generated by Generium top domains

Generium top domains revenue over 3 years

Revenue for Generium top domains


Total visits to Generium's top domains

Understand Generium market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Generium's top domains

Analyze Generium engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Generium's top domains

See how Generium keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Generium

These are the website technologies, by industry, used by Generium top domains

Widget (4)

reCAPTCHA

reCAPTCHA

Advertising (3)

DoubleClick

DoubleClick

Conversion & Analytics (3)

Google Analytics

Google Analytics

Social (2)

Instagram

Instagram

More Technologies

6

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Generium

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGenerium launches omalizumab biosimilar.Selexis and Generium launched an omalizumab biosimilar on the Russian market; Remsima sales hit a record high for Celltrion Healthcare; Xbrane Biopharma shares long-term results for its ranibizumab biosimilar.
NewsGenerium launched Genolar on Feb 9th '22.Selexis and Generium shared that they have launched Genolar, a biosimilar for omalizumab (Xolair) on the Russian market for the treatment of persistent atopic bronchial asthma and resistant chronic idiopathic urticaria for patients aged 6 years and up.
NewsGenerium launches Sputnik V vaccine.GENERIUM launched the production of Sputnik V vaccine

See all Generium signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.